PT  - JOURNAL ARTICLE
AU  - Nicola Johnstone
AU  - Chiara Milesi
AU  - Olivia Burn
AU  - Bartholomeus van den Bogert
AU  - Arjen Nauta
AU  - Kathryn Hart
AU  - Paul Sowden
AU  - Philip WJ Burnet
AU  - Kathrin Cohen Kadosh
TI  - Anxiolytic effects of a galacto-oligosaccharides prebiotic in healthy female volunteers are associated with reduced negative bias and the gut bacterial composition
AID  - 10.1101/19011403
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19011403
4099  - http://medrxiv.org/content/early/2019/12/04/19011403.short
4100  - http://medrxiv.org/content/early/2019/12/04/19011403.full
AB  - Current research implicates pre- and probiotic supplementation as potential mediators for improving symptomology in numerous physical and emotional ailments. The alteration of emotional states via nutrient intake is an attractive concept for clinicians and consumers alike and may be an efficient channel to improved well-being. Here we focus on the period of late adolescence, which is a time of emotional refinement via maturation that significantly influences emotional, social and physical well-being in later years. Effective interventions such as nutritional supplementation in this age group have the potential to offset health-related costs in later life. In this study we examined multiple indices of mood and well-being in 64 healthy females in late adolescence in a 4-week double blind, placebo controlled Galacto-oligosaccharide (GOS) prebiotic supplement intervention. We also obtained stool samples at baseline and follow-up for microbiome sequencing and analyses. We found effects of the GOS intervention on sub-clinical self-reported high trait anxiety, attentional bias, and bacterial abundance, suggesting that dietary supplementation with a GOS prebiotic may be influential in improving indices of pre-clinical anxiety.Competing Interest StatementAN is an employee of FrieslandCampina.Clinical TrialNCT03835468Funding StatementThis research was supported by faculty research fund from the Faculty of Health and Medical Sciences, University of Surrey, UK to KCK. FrieslandCampina provided the galacto-oligosaccharides (GOS, prebiotics) used in this study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and scripts for reproducing analysis in this manuscript are freely available. https://osf.io/ngmsu/